Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

@article{Brewer2012CopperEZ,
  title={Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease},
  author={George J. Brewer},
  journal={BioFactors},
  year={2012},
  volume={38}
}
  • G. Brewer
  • Published 2012
  • Biology, Medicine
  • BioFactors
In this special issue about biofactors causing cognitive impairment, we present evidence for and discuss two such biofactors. One is excess copper, causing neuronal toxicity. The other is zinc deficiency, causing neuronal damage. We present evidence that Alzheimer's disease (AD) has become an epidemic in developed, but not undeveloped, countries and that the epidemic is a new disease phenomenon, beginning in the early 1900s and exploding in the last 50 years. This leads to the conclusion that… Expand
Alzheimer’s disease causation by copper toxicity and treatment with zinc
TLDR
The inorganic copper hypothesis fits well with the Squitti group data, and it is postulate that the new emerging environmental factor partially causal of the AD epidemic is ingestion of inorganic Copper from drinking water and taking supplement pills, along with a high fat diet. Expand
Copper and Zinc Dysregulation in Alzheimer's Disease.
TLDR
The role of AD-related neurodegeneration and cognitive decline triggered by the imbalance of two endogenous metals: copper and zinc is focused on. Expand
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
TLDR
A better understanding of Cu ions’ current status in several AD features is presented, and a short review of the modern therapeutic approach in chelation therapy, with the main focus on Cu ions is discussed. Expand
Copper in Wilson’s and Alzheimer’s Diseases, Copper-Lowering Therapy in Cancer and Other Diseases, and Copper Deficiency
Wilson’s disease is reviewed in some depth, providing the tools to recognize and diagnose this inherited disease of copper toxicity. Alzheimer's disease is a second disease, with Wilson's diseaseExpand
Disruption of zinc homeostasis and the pathogenesis of senile dementia.
TLDR
Zn acts as a contributor to Alzheimer's disease in the oligomerization, and as a protector in the neurotoxicity of Alzheimer's β-amyloid protein, and the possible role of carnosine (β-alanyl histidine) as a protective substance for neuronal injury is discussed. Expand
Inorganic Copper, or Copper-2, Ingestion as a Major Causal Factor for the Alzheimer’s Disease Epidemic—The Web of Evidence
In this chapter nine pieces of evidence will be brought together to make an overwhelming web of evidence that copper-2 ingestion is an environmental cause of the Alzheimer’s disease (AD) epidemic inExpand
Avoiding Alzheimer’s disease: The important causative role of divalent copper ingestion
  • G. Brewer
  • Medicine
  • Experimental biology and medicine
  • 2019
TLDR
The author hypothesizes that the environmental change causing the epidemic of Alzheimer’s disease is ingestion of divalent copper, based on data indicating that food copper is primarily monovalent copper, and humans evolved safe ways of channeling monovalENT copper, but not divalent Copper. Expand
Copper in Brain and Neurodegeneration
Cu is an essential element for the brain. It is involved in neurotransmission and is required for several cuproenzymes of the brain. Cu deficiency and Cu excess are associated with Menkes disease andExpand
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
TLDR
The involvement of copper in AD is controversial, as some studies show a copper deficiency in AD, and consequently a need to enhance copper levels, while other data point to copper overload and therefore a needs to reduce copper levels. Expand
Metals in the causation and treatment of Wilson’s disease and Alzheimer’s disease, and copper lowering therapy in medicine
Abstract It is clear that copper accumulation and toxicity is the cause of Wilson’s disease. It is also well established that zinc therapy is effective in treating Wilson’s disease by a mechanism ofExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Treatment of Alzheimer's disease by zinc compounds
At the onset of Alzheimer's disease (AD), specific lesions occur in the hippocampus, i.e., neuropile‐capillary amyloid (AM) plaques and neuronal paired‐helical filaments (PHF)‐neurofibrillary tanglesExpand
Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease
  • D. Sparks, B. Schreurs
  • Medicine, Chemistry
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2003
TLDR
It is shown that the addition of trace amounts of copper to water given to cholesterol-fed rabbits can induce β-amyloid accumulation, including senile plaque-like structures in the hippocampus and temporal lobe, and can significantly retard the ability of rabbits to learn a difficult trace conditioning task. Expand
Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.
TLDR
Water quality may have a significant influence on disease progression and Ab neuropathology in AD as well as administration of distilled water, which produced a reduction in the expected accumulation of Ab in three separate animal models. Expand
Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability
TLDR
Arsenic positively correlated with Mini-Mental State Examination score and the arsenic correlation might be caused by the major contribution of seafood consumption to intake of both arsenic and docosahexaenoic acid, of which the latter may delay AD. Expand
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction
TLDR
The data support the idea that controlling the brain Zn2+ homeostasis may be beneficial in the treatment of AD. Expand
Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
TLDR
The data presented document that zinc is effective as a sole therapy in the long-term maintenance treatment of Wilson's disease and that it has a low toxicity. Expand
Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein
TLDR
It is demonstrated for the first time that Cu-metallated full-length APP ectodomain induces neuronal cell death in vitro and suggests that targeting of inhibitors to histidine residues at positions 147 and 151 of APP could significantly alter the oxidative potential of APP. Expand
Is cognitive function linked to serum free copper levels? A cohort study in a normal population
TLDR
Evidence suggests the need for a shift of focus from total to free copper levels in the study of mental decline and sustains the notion that free copper may be a risk factor in the development of impaired cognition. Expand
The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
TLDR
Copper ion-mediated toxicity may contribute to neurodegeneration in Alzheimer's disease. Expand
Subclinical Zinc Deficiency in Alzheimer’s Disease and Parkinson’s Disease
TLDR
Results showed a significantly lower blood zinc in patients with Alzheimer’s and patients with Parkinson's disease than in controls, and these patients are probably zinc deficient because of nutritional inadequacy. Expand
...
1
2
3
4
5
...